World at a crossroads as Africa is called to action in fight against HIV after US paused humanitarian support to developing nations
Much of the discussion at IAS 2025 focused on political will. With international funding under pressure – most notably, cuts to US HIV funding in early 2025 – African governments are being urged to lead with urgency. One of the most sobering realities of IAS 2025 was the impact of a political decision on the HIV response.
HIV/Aids: Kenya to start administering newly approved Lenacapavir antiretroviral drug in January
Lenacapavir received approval from the US Food and Drug Administration (FDA) in June 2025 and has been subsequently endorsed in the updated World Health Organization (WHO) guidelines on long-acting HIV prevention, released in July 2025.
Kenya nominated to pilot next-generation HIV prevention drug lenacapavir in Africa
The Kenyan parliamentary delegation attending the IAS 2025 conference led by Dr James Nyikal, Chair of the Departmental Committee on Health, called for legislative support in advancing the sustainability of the gains made in the HIV response.
Study finds sugar and artificial sweeteners raise children’s risk of early puberty, lead to shorter adult height
The Make America Healthy Again (MAHA) report named artificial sweeteners as one of the possible contributors to the US childhood chronic disease epidemic. In 2023, the World Health Organization (WHO) determined that aspartame is “possibly carcinogenic” and ineffective for weight loss.
Health workers blast Nairobi Governor Sakaja as a joker, carefree and ignorant after failing to end three-month-long clinical officers’ strike
Speaking during a press briefing in Nairobi, KUCO National Chair Peterson Wachira expressed deep concern over what he termed as the ‘carefree attitude’ of the county government in addressing the ongoing healthcare inactivity.
While Africa has been vital to development of HIV medication, Trump’s funding cuts to UN threatens vaccine research
Significant advances have included clinical trials for lenacapavir, the world’s only twice-a-year shot to prevent HIV, recently approved for use by the US Food and Drug Administration. One study to show its efficacy involved young South Africans.
Diminishing interest in President Ruto in Kakamega prods him to deploy military to complete stalled hospital project
The 900-bed Hospital is expected to create 5,000 jobs, promote medical tourism and provide learning and practical exposure to medical students. The completion of the hospital that was intended to take pressure off Kenyatta National Hospital in Nairobi and Moi Teaching and Referral in Eldoret by specialising in – among other services – the treatment of cancer, dialysis, hypertension and diabetes.
Behind glossy picture of European demographics, it emerges that Covid vaccines may have fixed the power and flair of women to bear children
The drop in natality in the Czech Republic in 2022 could not be explained by demographic factors. Total fertility rate – which is independent of the number of women and their age structure – dropped sharply in 2022 and has been decreasing ever since. The data for 2024 show that the Czech TFR has decreased further to 1.37.
Covid fraud: Scientists tell leading European public broadcaster ‘Never seen science so compromised’
Earlier this year, The Wall Street Journal reported that censorship extended to intelligence agencies. In August 2021, the Biden administration excluded the FBI from a White House intelligence briefing, preventing the bureau from presenting evidence supporting the lab-leak theory.
UN: HIV catastrophe looms in poor countries unless hole left after US funding pause is plugged
The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January when US President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the US AID agency.
